- Home
- EMD vs STLN Comparison
EMD vs STLN Comparison
Compare EMD & STLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
SELL
N/A
Current Price
$6.46
Company Overview
Basic Information| Metric | EMD | STLN |
|---|---|---|
| Founded | 2003 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 609.8M | 628.8M |
| IPO Year | 2003 | 2020 |
Fundamental Metrics
Financial Performance| Metric | EMD | STLN |
|---|---|---|
| Price | $9.45 | $6.46 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.40 |
| AVG Volume (30 Days) | 255.9K | ★ 1.3M |
| Earning Date | 01-01-0001 | 11-12-2026 |
| Dividend Yield | ★ 10.25% | N/A |
| EPS Growth | N/A | ★ 23.94 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $502,729,000.00 |
| Revenue This Year | N/A | $32.28 |
| Revenue Next Year | N/A | $32.92 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 27.79 |
| 52 Week Low | $9.10 | $5.76 |
| 52 Week High | $11.30 | $7.13 |
Technical Indicators
Market Signals| Indicator | EMD | STLN |
|---|---|---|
| Relative Strength Index (RSI) | 43.87 | 50.25 |
| Support Level | $9.10 | $6.04 |
| Resistance Level | $10.71 | $6.98 |
| Average True Range (ATR) | 0.18 | 0.34 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 55.37 | 48.57 |
Price Performance
Historical Comparison EMD
STLN
About EMD Western Asset Emerging Markets Debt Fund Inc
Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management and long term investment company. The primary investment objective of the company is to seek high current income, and the secondary objective is to seek capital appreciation.
About STLN Starling Oncology Inc. Common Stock
Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.